High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients

Figure 1 Immunohistochemical analysis of epidermal growth factor-like repeats and discoidin I-like domains 3 in hepatocellular carcinoma patients. A: Negative expression of epidermal growth factor-like repeats and discoidin I-like domains 3 protein; B: Low expression level of epidermal growth factor-like repeats and discoidin 1-like domains 3 protein; C, D: High expression level of epidermal growth factor-like repeats and discoidin 1-like domains 3 protein. A, B: Original magnification × 100; C, D: Original magnification × 200.

Figure 2 Overall survival rate of hepatocellular carcinoma patients estimated according to the epidermal growth factor-like repeats and discoidin I-like domains 3 expression level in hepatocellular carcinoma tissue samples (Kaplan-Meier method) with immunohistochemical staining.